BioAge Labs, Inc.
BIOA
$10.60
$0.171.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.62% | 91.04% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.62% | 91.04% | -- | -- | -- |
| Cost of Revenue | 22.78% | 83.72% | 27.44% | -7.52% | 89.51% |
| Gross Profit | -25.71% | -82.63% | -11.43% | 17.78% | -66.48% |
| SG&A Expenses | 1.09% | 13.98% | 14.08% | 41.22% | 52.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.93% | 57.27% | 24.21% | 1.79% | 78.03% |
| Operating Income | -18.42% | -54.29% | -12.07% | 6.51% | -62.23% |
| Income Before Tax | -21.03% | -72.13% | -22.78% | 13.82% | -58.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.03% | -72.13% | -22.78% | 13.82% | -58.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.03% | -72.13% | -22.78% | 13.82% | -58.77% |
| EBIT | -18.42% | -54.29% | -12.07% | 6.51% | -62.23% |
| EBITDA | -18.41% | -54.26% | -12.00% | 6.56% | -62.37% |
| EPS Basic | 3.24% | -45.26% | -22.21% | 91.60% | 92.42% |
| Normalized Basic EPS | 3.22% | -45.25% | -22.20% | 91.60% | 92.42% |
| EPS Diluted | 3.24% | -45.26% | -22.21% | 91.60% | 92.42% |
| Normalized Diluted EPS | 3.22% | -45.25% | -22.20% | 91.60% | 92.42% |
| Average Basic Shares Outstanding | 25.07% | 18.50% | 0.47% | 925.87% | 1,995.27% |
| Average Diluted Shares Outstanding | 25.07% | 18.50% | 0.47% | 925.87% | 1,995.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |